A Phase 2 trial published in the New England Journal of Medicine (2023) reported significant weight reduction with retatrutide over 48 weeks, and further trials are registered on ClinicalTrials
Yes, you can become pregnant while taking GLP-1 medications like semaglutide, but current evidence recommends discontinuing these medications before attempting conception
Each step outward in receptor coverage has produced larger metabolic-research signals in the published literature, though the biology behind that progression is more complicated than a simple more targets, better outcomes framework suggests
When to contact your provider
Regulatory Status Retatrutide is an investigational drug and has not been approved by the FDA for any use, including weight management during menopause
Additional methylcobalamin: consider 1000mcg sublingual if borderline deficient at baseline Alpha-lipoic acid: 300-600 mg daily CoQ10: 100-200 mg daily Strategy 7: Early Intervention If dysesthesia develops, its a metabolic SOS signal
